Author

Jeffrey B. Hargis

Observed names: J B Hargis, J. B. Hargis, J. Hargis, Jeffrey B Hargis, Jeffrey Hargis, JeffreyB. Hargis

Observed institutions: University of Louisville, Uniformed Services University of the Health Sciences, Baylor College of Medicine, Norton Healthcare, Walter Reed National Military Medical Center, Jewish Hospital, Jewish Hospital and St. Mary's HealthCare

OpenAlex ID: A5042537898

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

2020 · Sandra M Swain, David Miles, et al. · The Lancet Oncology · 960

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.

1996 · G L Rosner, J B Hargis, et al. · Journal of Clinical Oncology · 177

Opportunistic pulmonary infections with fludarabine in previously treated patients with low‐grade lymphoid malignancies: A role for pneumocystis carinii pneumonia prophylaxis

1995 · John C. Byrd, Jeffrey B. Hargis, et al. · American Journal of Hematology · 108

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.

1994 · A A Miller, J B Hargis, et al. · Journal of Clinical Oncology · 80

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study.

1995 · R C Lilenbaum, M J Ratain, et al. · Journal of Clinical Oncology · 64

A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial high grade malignant glioma (MG) who have undergone surgery with carmustine (BCNU) wafer insertion

2005 · R. V. Larocca, T. W. Vitaz, et al. · Journal of Clinical Oncology · 33

Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)

2022 · Soliman Hatem, Jeffrey Hargis, et al. · Cancer Research · 21

Osteogenic sarcoma with skin metastases

1995 · Rickey C Myhand, Ping-Hsin Hung, et al. · Journal of the American Academy of Dermatology · 20

Resumption of Menses with Initiation of Letrozole After Five Years of Amenorrhea on Tamoxifen: Caution Needed When Using Tamoxifen Followed by Aromatase Inhibitors

2006 · Jeffrey B. Hargis, Steven T. Nakajima · Cancer Investigation · 17

Granulomatous Pneumocystis carinii Pneumonia in Patients with Low-Grade Lymphoid Malignancies: A Diagnostic Dilemma

1996 · K. E. Kester, J. C. Byrd, et al. · Clinical Infectious Diseases · 16

A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application

2021 · David Richardson, Lin Zhan, et al. · Breast Cancer Research and Treatment · 14

PDF

Induction chemotherapy in Jehovah's Witnesses with leukaemia

1990 · JeffreyB. Hargis, DavidJ. Waddell, et al. · The Lancet · 13

High-Grade Glioma Treated With Surgery; Carmustine Wafer; Postoperative Radiation; and Procarbazine, Lomustine, and Vincristine Chemotherapy

2005 · Renato LaRocca, Shawn Glisson, et al. · Neurosurgery Quarterly · 12

Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a cancer and leukemia group B study

1992 · Jeffrey B. Hargis, James R. Anderson, et al. · Cancer Chemotherapy and Pharmacology · 10

Leukemic thyroiditis as the initial relapsing sign in a patient with acute lymphocytic leukemia and blast expression of the neural cell adhesion molecule

1997 · John C. Byrd, Nancy S. Dow, et al. · American Journal of Hematology · 7

PDF

The effect of rhGM‐CSF on the proliferation of osteogenic sarcoma cells

1991 · W. Jeffrey Baker, Jeffrey B. Hargis, et al. · American Journal of Hematology · 4

High-dose (HD) irinotecan in patients with recurrent unresectable high-grade gliomas on glucoronidation-enhancing anticonvulsants (GEACs): A phase I/II study

2004 · R. V. Larocca, A. Cervera, et al. · Journal of Clinical Oncology · 3

Letter to the editor: “Mexican aspirin”—a derogatory term

1990 · Guillermo J. Ruiz‐Argüelles, Donato Alarcon‐Segovia, et al. · American Journal of Hematology · 2

Compassionate-use Oxaliplatin with Bolus 5-Fluorouracil/Leucovorin in Heavily Pretreated Patients with Advanced Colorectal Cancer

2004 · Renato V. LaRocca, Shawn D. Glisson, et al. · Southern Medical Journal · 1

Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab

2026 · Marija Balic, Gong Tang, et al. · JCO Precision Oncology

PDF

The impact of advanced or metastatic breast cancer or its treatment on productivity, energy, and physical activity among palbociclib participants of the MADELINE study

2020 · D. Richardson, L. Zhan, et al. · European Journal of Cancer

The effect of neutropenia on patient-reported functioning and quality of life (QOL) among palbociclib participants of the MADELINE study.

2020 · David Richardson, Lin Zhan, et al. · Journal of Clinical Oncology

Abstract P1-19-41: Relationship between depression status and daily and weekly mood in the MADELINE study

2020 · David Richardson, Lin Zhan, et al. · Cancer Research

Systemic therapy for early breast cancer.

2009 · Jeffrey B Hargis, Dharamvir Jain · PubMed

A phase II clinical trial utilizing maximum medical and surgical cytoredutive treatments for patients with metastatic colorectal cancer to the liver

2009 · S. D. Glisson, R. V. LaRocca, et al. · Journal of Clinical Oncology

Works count: 28

Citation count: 1,562

H-index: 12

I10-index: 14